"What has been really disturbing in the last six or seven years is to watch the buck-passing between the federal and state governments about the processes we need to go through to then decide not to fund something," said chair and co-founder Felicity McNeill PSM.
'System-level problems require system-level solutions'
August 9, 2021 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
New Stories
-
New treatment listed on PBS, offering twice-yearly dosing for Australians with relapsing MS
January 9, 2026 - - Latest News -
The value of looking back and the importance of seeing the 'smoke signals' on reform
January 8, 2026 - - Latest News -
Vaxxas appoints former global vaccines leader to head global commercialisation push
January 8, 2026 - - Australian Biotech -
Reform was justified because a committee prioritising clinical considerations was 'culturally' problematic
January 4, 2026 - - Latest News -
AdAlta and SHcell launch cancer collaboration to progress breakthrough CAR-T therapy
January 2, 2026 - - Australian Biotech -
Cabinet documents from the year that led to transformational changes
January 1, 2026 - - Latest News -
US pricing push gets real with Australia included in comparison list
December 22, 2025 - - Latest News

